Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Point Biopharma Global Inc (PNT)
Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,332,113
  • Shares Outstanding, K 106,569
  • Annual Sales, $ 226,580 K
  • Annual Income, $ 98,290 K
  • 60-Month Beta 0.00
  • Price/Sales 5.87
  • Price/Cash Flow 13.31
  • Price/Book 3.12
Trade PNT with:
  • Price/Earnings ttm 13.87
  • Earnings Per Share ttm 0.90
  • Most Recent Earnings $-0.23 on 11/13/23
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 39.01%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.29
  • Number of Estimates 8
  • High Estimate -0.15
  • Low Estimate -0.36
  • Prior Year 1.53
  • Growth Rate Est. (year over year) -118.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.43 +0.56%
on 12/19/23
14.35 -12.89%
on 12/13/23
-1.26 (-9.16%)
since 11/24/23
3-Month
6.57 +90.26%
on 10/02/23
14.35 -12.89%
on 12/13/23
+5.68 (+83.28%)
since 09/26/23
52-Week
6.57 +90.26%
on 10/02/23
14.35 -12.89%
on 12/13/23
+5.62 (+81.69%)
since 12/23/22

Most Recent Stories

More News
Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NASDAQ:MRTX),(NYSE:LLY),(NASDAQ:PNT) EQNX::TICKER_END

ONCY : 1.1600 (+13.73%)
ONC.TO : 1.55 (+13.14%)
EXEL : 22.11 (+0.91%)
MRTX : 58.70 (-0.17%)
LLY : 750.21 (-0.98%)
PNT : 12.50 (+0.16%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VSTO, OLK, PNT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VSTO : 30.94 (+0.45%)
OLK : 22.61 (+0.27%)
PNT : 12.50 (+0.16%)
Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race

Major pharmaceutical companies are continuing to make substantial acquisitions in the field of oncology, sparking enthusiasm in the market. Bristol Myers Squibb (NYSE:BMY) just announced its plan to buy...

DTC.CN : 1.8600 (+2.20%)
BMY : 50.72 (-0.39%)
MRTX : 58.70 (-0.17%)
LLY : 750.21 (-0.98%)
PNT : 12.50 (+0.16%)
DTCFF : 1.3501 (-0.36%)
Moore Kuehn Encourages TWNK, LVOX, ACER, and PNT Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

TWNK : 33.30 (-0.15%)
LVOX : 3.73 (+0.81%)
ACER : 0.6601 (-17.95%)
PNT : 12.50 (+0.16%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWLI, MRTX, SLGC, PNT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NWLI : 487.60 (+0.53%)
MRTX : 58.70 (-0.17%)
SLGC : 2.10 (-4.55%)
PNT : 12.50 (+0.16%)
Why Point BioPharma Global Stock Skyrocketed 86% This Week

Point Biopharma is being acquired by Eli Lilly. Here's what investors need to know.

PNT : 12.50 (+0.16%)
LLY : 750.21 (-0.98%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PNT, KITT, TRHC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PNT : 12.50 (+0.16%)
KITT : 0.2810 (-19.71%)
TRHC : 10.50 (+0.86%)
Why Eli Lilly Stock Was Looking Sickly Today

Investors weren't necessarily satisfied with their company's latest asset buy.

LLY : 750.21 (-0.98%)
PNT : 12.50 (+0.16%)
Why Shares of Point Biopharma Global Are Soaring Tuesday

The company entered into a buyout agreement with Eli Lilly.

LNTH : 64.70 (-1.02%)
LLY : 750.21 (-0.98%)
PNT : 12.50 (+0.16%)
Shareholder Alert: Ademi LLP investigates whether POINT Biopharma Global, Inc. has obtained a Fair Price in its transaction with Eli Lilly

/PRNewswire/ -- Ademi LLP is investigating POINT (Nasdaq: PNT) for possible breaches of fiduciary duty and other violations of law in its transaction with Eli...

PNT : 12.50 (+0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

POINT Biopharma Global Inc. is a radiopharmaceutical company. It builds a platform for the clinical development and commercialization of radioligands which fight cancer. POINT Biopharma Global Inc., formerly known as Research Alliance Corp., is based in INDIANAPOLIS.

See More

Key Turning Points

3rd Resistance Point 12.53
2nd Resistance Point 12.52
1st Resistance Point 12.51
Last Price 12.50
1st Support Level 12.49
2nd Support Level 12.48
3rd Support Level 12.47

See More

52-Week High 14.35
Last Price 12.50
Fibonacci 61.8% 11.38
Fibonacci 50% 10.46
Fibonacci 38.2% 9.54
52-Week Low 6.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar